On Demand Education

Updates in Screening and Surveillance for Barrett’s Esophagus

We have become excellent at treating Barrett’s esophagus (BE) related neoplasia. But to reduce the instance of esophageal adenocarcinoma (EAC) we need to increase the population under surveillance and leverage risk stratification tools to personalize the management of non-dysplastic BE.

Sri Komanduri, MD, FASGE, AGAF Director of Endoscopy Northwestern University